Sterghios A. Moschos

Oh, and a new ‘omits is here #ats2025 - coughomics from Hyfe Inc.

Meet us at poster #152 to find out about the clinical evidence, obtained at primary care, even at resource limited settings

/end

Mark Sanders, Scott Fleming, and myself are here to partner, collaborate, and help you build the clinical evidence you need to prove your new solution to unmet need does what it intends, in the lung, non-invasive.

6/n

PulmoBioMed is presenting at 3:00 pm today the first solution to true, contamination-free, distal small airway fluid sample collection, that works with your analytical workflow.

5/n

We have the best tools to measure these things for the first time in the history of medicine. Yet we remain stumped by the lack of the right sample.
4/n

And how do you do it when a liquid sample from inside the lung can be obtained, at best, once per patient (lavage)- when mucus/sputum is no longer recommended by ADLM?

3/n.

The old problems though remain. How do you find the right patients?

How do you measure if the drug works- where it’s meant to, and how it’s meant to?

2/n

At the #ATS2025 #RIS innovation in Respiratory Medicine is truly reaching new heights, poised to transform patient quality of life.

From repurposing statins for asthma to surfactant peptidomimetics and targeted degradation of kinases, the field is ripe and ready to resolve unmet need.

1/n

Stick to the Wellcome Trust. I’m confident they will go out of their way to bridge at least part of the gap in the space of neglected disease